DXM + Moclobemide

https://dxm-atlas.org/en/interactions/moclobemide/

Compare

Key points for this combination

Moclobemide inhibits MAO-A. A small human study also found reduced DXM O-demethylation with unchanged DXO N-demethylation [43]. That study measured metabolism. Another source reports a fatal DXM–moclobemide overdose [27]. One such case cannot establish the frequency of complications during recreational use.

General concepts in this text

Metabolite

A substance formed when another substance is chemically transformed in the body.

Some transformation products retain pharmacological activity.

Sources: Metabolite

MAO-A

A form of the MAO enzyme involved in breaking down some chemical messengers, including serotonin.

These messengers are monoamines. MAO-A and MAO-B are two different forms of monoamine oxidase.

Sources: MAO-A

Drug metabolism

Chemical transformation of a medicine in the body.

The resulting substances are metabolites. Transformation can reduce or increase pharmacological activity.

Sources: Drug metabolism

Demethylation

A chemical change that removes one or more methyl groups from a compound.

A methyl group contains one carbon atom and three hydrogen atoms.

Sources: Demethylation

How well is this understood?

Mechanism confidence: high

Confidence in the mechanism: high

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: medium

Confidence in direct human evidence involving DXM: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Measurements of drug concentration or metabolism.Overdose data; they do not show outcome frequency at ordinary exposures.

How to read ratings and study limits

How do the substances interact?

Can the amount reaching the body change?

Mechanism: 2D6 — CYP2D6 metabolism
ⓘ

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

How can the effects add up?

Mechanism: MAO — Monoamine oxidase
ⓘ

MAO — monoamine oxidase

An enzyme involved in breaking down serotonin.

Breakdown and reuptake are different processes.

Sources: MAO — monoamine oxidase
Serotonin toxicity

A condition caused by excessive serotonin activity in the nervous system.

Also called serotonin syndrome. Features can include tremor and involuntary muscle jerks, raised body temperature, a fast heartbeat, agitation or confusion.

Sources: Serotonin toxicity

In the glossary

Sources

Check the review’s wording

MAO-A inhibition plus direct human inhibition of DXM O-demethylation; fatal overdose reported [27, 43]

Combination row in the review: 2D6 — CYP2D6 metabolism; MAO — Monoamine oxidase

Related entries

Reference

Open the source and related combinations →